What Is Cytotoxicity?

Cytotoxicity is the property of a substance, material, or cell that causes damage or death to living cells. In laboratory practice the word usually refers to a measured quantity: the degree to which exposure to a test article reduces the viability, proliferation, or membrane integrity of a cultured cell population. It is the first and most widely used endpoint in biological safety evaluation, and it also serves as a primary readout in drug discovery, where killing a target cell is the intended effect rather than an unwanted one.

The concept comes from toxicology and cell culture, and it has been formalized by standards bodies for use in medical device and materials engineering. Cytotoxicity screening is attractive because it is fast, sensitive, inexpensive, and reduces reliance on animal testing, so it is normally run before any in vivo study is considered.

Mechanisms of Cell Injury

Cells die by distinguishable routes, and the route matters for interpretation. Necrosis follows acute physical or chemical insult and involves swelling, loss of plasma membrane integrity, and release of cytoplasmic contents into the surrounding medium. Apoptosis is a regulated program marked by caspase activation, chromatin condensation, and exposure of phosphatidylserine on the outer leaflet of the membrane. Between these lie autophagic death, pyroptosis, and ferroptosis. Immune cells add a biological dimension: cytotoxic T lymphocytes and natural killer cells kill target cells deliberately through perforin and granzyme release, a mechanism that antibody-dependent cellular cytotoxicity assays are designed to quantify.

Cytotoxicity Assays

Assays fall into two families. Viability assays report the number of metabolically active cells, using tetrazolium reagents such as MTT, resazurin reduction, or luminescent detection of cellular ATP. The Assay Guidance Manual chapter on cell viability assays compares these formats and notes that some reagents are themselves toxic over a few hours of exposure, which constrains assay duration. Cell death assays instead detect the dead fraction directly, most commonly by measuring lactate dehydrogenase released through a compromised membrane, or by staining with impermeant dyes. Guidance on in vitro methods to measure dead cells sets out how these markers should be paired, since a single endpoint can mislead when a compound arrests growth without killing.

Results are normally expressed as a dose-response curve and reduced to an IC50 or LC50 value, the concentration producing half-maximal inhibition or lethality. Comparability depends on controlling cell line, seeding density, serum content, and exposure time, all of which shift the curve.

Standardized Testing for Materials and Devices

For medical devices, cytotoxicity testing is governed by ISO 10993-5, the in vitro cytotoxicity part of the biological evaluation series. The standard defines three approaches: testing an extract of the material, direct contact between material and cell monolayer, and indirect contact through agar overlay or a filter. A reduction in cell viability greater than 30 percent relative to an untreated control is taken as a cytotoxic effect. Practical experience shows the limits of the method. An interlaboratory study of ISO 10993-5 testing on an identical device found that laboratories reached opposite conclusions at close to even odds, a result attributed to unspecified choices in extraction conditions and cell handling.

Applications

Cytotoxicity assessment is used across a range of disciplines, including:

• Biocompatibility screening of implants, catheters, dental materials, and wound dressings
• Preclinical oncology, where potency of a candidate compound is expressed as an IC50
• Nanomaterial and nanoparticle safety evaluation
• Environmental and occupational toxicology of chemicals and airborne particulates
• Potency and release testing of cell therapies and therapeutic antibodies
• Quality control of manufacturing residues, sterilants, and leachables from packaging